Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Treatment effectiveness of TB patients from different groups of population in Moscow

Elena Bogorodskaya, Sergey Borisov, Evgeny Belilovskiy, Ludmila Rybka, Michael Sinitsyn
European Respiratory Journal 2016 48: PA2738; DOI: 10.1183/13993003.congress-2016.PA2738
Elena Bogorodskaya
1Department of Public Health in the Moscow City, Moscow Scientific and Clinical Center for TB Control, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sergey Borisov
1Department of Public Health in the Moscow City, Moscow Scientific and Clinical Center for TB Control, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evgeny Belilovskiy
1Department of Public Health in the Moscow City, Moscow Scientific and Clinical Center for TB Control, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ludmila Rybka
1Department of Public Health in the Moscow City, Moscow Scientific and Clinical Center for TB Control, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Sinitsyn
1Department of Public Health in the Moscow City, Moscow Scientific and Clinical Center for TB Control, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction: Moscow has one of the lowest tuberculosis (TB) epidemiological rate in Russia. At the same time, the impacts of significant migration from CIS countries and Russian regions (MG), homeless (HML) and HIV are the major challenges of TB control in the megapolis. Differentiation of treatment outcomes evaluation for these groups of patients in depend on history of previous treatment are needed for targeted measures.

Methods: Treatment outcomes for 2013 cohort (2803 not-MDR TB patients) were analyzed in the Moscow in the beginning of 2015. Cohorts of HIV-negative (HIVn) and HIV-positive (HIVp) residents (RS), as well as HML and MG were evaluated separately for new TB cases (NC), TB relapses (RLC) and retreatment TB cases (RTC).

Results: Treatment success rate (TSR) of NC was highest in 1398 HIVn RS: 84.6% (95% CI: 82.6-86.5) in comparison with201 HIVp RS patients (54.7%, 47.6-61.7), 623 MG: (56.0%, 52.0-60.0) and 97 HML (48.5%, 38.2-58.8), p<0.01.

NC from HIVp RS had predictably the highest level of death rate: 27.9% (21.8-34.6) vs. 3.9%, 8.2% and 2.7% for NC from RS, HML and MG, accordingly (p<0.01).

TSR for 194 RLC from RS (69.1%, 59.7-73.1) was higher (p<0.05) than TSR for 33 RLC from HIVp RS and 48 RLC from MG: 51.5% and 39.6%, accordingly.

Both MG cohorts: 623 NC and 48 RLC, showed high level of “not evaluated” outcomes: 37.1% (33.3-41.0) and 50.0% (35.2-64.8), defined particularities of the moving population, in contrast of RS cohorts (1.5% -1.6%).

74 RTC patients from RS showed TSR: 39.2% (28.0-51.2).

Conclusions: Evaluations of treatment effectiveness for patients from different strata of population allows define directions of purposeful activities to improvement of TB control in Moscow.

  • Tuberculosis - management
  • Treatments
  • Epidemiology
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Treatment effectiveness of TB patients from different groups of population in Moscow
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Treatment effectiveness of TB patients from different groups of population in Moscow
Elena Bogorodskaya, Sergey Borisov, Evgeny Belilovskiy, Ludmila Rybka, Michael Sinitsyn
European Respiratory Journal Sep 2016, 48 (suppl 60) PA2738; DOI: 10.1183/13993003.congress-2016.PA2738

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Treatment effectiveness of TB patients from different groups of population in Moscow
Elena Bogorodskaya, Sergey Borisov, Evgeny Belilovskiy, Ludmila Rybka, Michael Sinitsyn
European Respiratory Journal Sep 2016, 48 (suppl 60) PA2738; DOI: 10.1183/13993003.congress-2016.PA2738
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Changes in MIRU-VNTR profiles are associated with treatment failures in tuberculosis patients
  • Implementing an IGRA (interferon-gamma release assay) based TB screening pathway prior to starting biological treatments – Experience from a UK university hospital
  • TB infection decreases asthma prevalence and severity of symptoms
Show more 10.2 Tuberculosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society